amifostine anhydrous has been researched along with Leukemia, Smoldering in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five patients were treated at an idarubicin dose of 18 mg/m2/day x 3, three of whom developed grade 3 diarrhea or mucositis." | 5.10 | A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes. ( Cortes, J; Davis, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, F; Kantarjian, HM; O'Brien, S; Thomas, D, 2002) |
| "Two patients had RAEB, four RA and one RARS." | 2.70 | Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes. ( Bourantas, KL; Christou, L; Kapsali, HD; Panteli, K; Tsiara, SN, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Manero, G | 1 |
| Faderl, S | 1 |
| Giles, F | 1 |
| Thomas, D | 1 |
| Cortes, J | 1 |
| O'Brien, S | 1 |
| Davis, J | 1 |
| Kantarjian, HM | 1 |
| Estey, E | 1 |
| Hofmann, WK | 1 |
| Seipelt, G | 1 |
| Ottmann, OG | 1 |
| Kalina, U | 1 |
| Koschmieder, S | 1 |
| Brücher, J | 1 |
| Frickhofen, N | 1 |
| Klausmann, M | 1 |
| Mitrou, PS | 1 |
| Hoelzer, D | 1 |
| Tsiara, SN | 1 |
| Kapsali, HD | 1 |
| Panteli, K | 1 |
| Christou, L | 1 |
| Bourantas, KL | 1 |
2 trials available for amifostine anhydrous and Leukemia, Smoldering
| Article | Year |
|---|---|
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes.
Topics: Adult; Amifostine; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy P | 2002 |
Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes.
Topics: Aged; Amifostine; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Blood Transfusion; | 2001 |
1 other study available for amifostine anhydrous and Leukemia, Smoldering
| Article | Year |
|---|---|
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.
Topics: Aged; Amifostine; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Drug Administration | 2000 |